Randall Kaye is CMO of Longboard Pharmaceuticals, Inc.. Currently has a direct ownership of 17,920 shares of LBPH, which is worth approximately $517,350. The most recent transaction as insider was on Sep 16, 2024, when has been sold 16,666 shares (Common Stock) at a price of $32.47 per share, resulting in proceeds of $541,145. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.9K
0% 3M change
n/a 12M change
Total Value Held $517,350

Randall Kaye Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 16 2024
SELL
Open market or private sale
$541,145 $32.47 p/Share
16,666 Reduced 48.19%
17,920 Common Stock
Sep 16 2024
BUY
Exercise of conversion of derivative security
$72,497 $4.35 p/Share
16,666 Added 32.52%
34,586 Common Stock
Aug 12 2024
SELL
Open market or private sale
$579,844 $34.79 p/Share
16,667 Reduced 48.19%
17,920 Common Stock
Aug 12 2024
BUY
Exercise of conversion of derivative security
$72,501 $4.35 p/Share
16,667 Added 32.52%
34,587 Common Stock
Feb 08 2024
BUY
Grant, award, or other acquisition
-
17,920 Added 50.0%
17,920 Common Stock
RK

Randall Kaye

CMO
La Jolla, CA

Track Institutional and Insider Activities on LBPH

Follow Longboard Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LBPH shares.

Notify only if

Insider Trading

Get notified when an Longboard Pharmaceuticals, Inc. insider buys or sells LBPH shares.

Notify only if

News

Receive news related to Longboard Pharmaceuticals, Inc.

Track Activities on LBPH